Partial unilateral lentiginosis
| Partial unilateral lentiginosis | |
|---|---|
| Synonyms | PUL |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Lentigines on one side of the body |
| Complications | None |
| Onset | Childhood or adolescence |
| Duration | Lifelong |
| Types | N/A |
| Causes | Unknown |
| Risks | Genetic predisposition |
| Diagnosis | Clinical diagnosis |
| Differential diagnosis | Neurofibromatosis, Segmental pigmentation disorder |
| Prevention | N/A |
| Treatment | Laser therapy, Topical depigmenting agents |
| Medication | N/A |
| Prognosis | Good |
| Frequency | Rare |
| Deaths | N/A |
Partial Unilateral Lentiginosis (PUL) is a rare cutaneous condition characterized by numerous lentigines grouped within an area of normal skin; these are usually present at birth or appear in early childhood, and do not cross the midline of the body.<ref>,
Andrews' Diseases of the Skin: clinical Dermatology, , 2006,</ref>
Clinical Presentation[edit]
The condition is characterized by the presence of multiple lentigines, which are small, pigmented spots on the skin that are darker than the surrounding skin. These spots are typically grouped within an area of normal skin and are usually present at birth or appear in early childhood. The lentigines do not cross the midline of the body, meaning they are present on only one side of the body.<ref>,
Andrews' Diseases of the Skin: clinical Dermatology, , 2006,</ref>
Diagnosis[edit]
The diagnosis of Partial Unilateral Lentiginosis is primarily based on the clinical presentation of the patient. A dermatologist may perform a skin biopsy to confirm the diagnosis and rule out other conditions that may present with similar symptoms.<ref>,
Andrews' Diseases of the Skin: clinical Dermatology, , 2006,</ref>
Treatment[edit]
There is currently no cure for Partial Unilateral Lentiginosis. Treatment is primarily aimed at managing the symptoms and improving the appearance of the skin. This may include the use of topical creams, laser therapy, or surgical removal of the lentigines.<ref>,
Andrews' Diseases of the Skin: clinical Dermatology, , 2006,</ref>
See Also[edit]
References[edit]
<references />
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Get started with evidence based, physician-supervised
affordable GLP-1 weight loss injections
Now available in New York City and Philadelphia:
- Semaglutide starting from $59.99/week and up
- Tirzepatide starting from $69.99/week and up (dose dependent)
✔ Evidence-based medical weight loss ✔ Insurance-friendly visits available ✔ Same-week appointments, evenings & weekends
Learn more:
Start your transformation today with W8MD weight loss centers.
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian


